StockData

Biofrontera vs Fortress Biotech

BFRI and FBIO side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How BFRI and FBIO compare

Fortress Biotech is the larger company, worth 5.3 times as much as Biofrontera ($73.9M against $13.9M).

Biofrontera grew revenue faster over the last twelve months (17.8% versus 15.5% for Fortress Biotech).

Fortress Biotech keeps more of each dollar of sales as profit, with a net margin of 163% compared with −13.8% at Biofrontera.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricBFRIFBIO
Size and price
Market cap$13.9M$73.9M
Share price$0.938$2.01
Change, 1 year−9.9%−22.4%
Change, 5 years−98.2%−95.7%
Beta (5Y)1.021.38
Employees9278
StockData Score
Total score99
Valuation score01 (better)
Growth score2 (better)1
Performance score23 (better)
Health score5 (better)4
Dividend score00
Valuation
P/S0.3× (better)1.1×
P/B2.3×0.5× (better)
FCF yield−57.0%–
Growth
Revenue growth (TTM)17.8% (better)15.5%
Revenue growth, 5Y average17.2% (better)6.8%
Profitability
Gross margin–65.6%
Operating margin−14.2% (better)−42.9%
Net margin−13.8%163% (better)
FCF margin−17.2%–
Return on equity−988%107% (better)
Return on invested capital–−261%
Financial health
Debt / equity0.000.21 (better)
Interest coverage–−3.0×
Current ratio1.183.96 (better)
Altman Z-score−6.18−1.75 (better)
Piotroski F-score36 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions19.7%15.9%
Held by insiders23.6%31.6%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.